AstraZeneca says its vaccine needs ‘additional study’

London, United Kingdom, Nov 26 – The head of British drug manufacturer AstraZeneca said on Thursday further research was needed on its Covid-19 vaccine after questions emerged over the protection it offers, but the additional testing is unlikely to affect regulatory approval in Europe. AstraZeneca and its partner, the University of Oxford, announced on Monday […]...

read more...

Published By: capitalfm - Thursday, 26 November